Zika Virus Antagonizes Type I Interferon Responses during Infection of Human Dendritic Cells

PLoS Pathogens

Volumn 13, Issue 2, 2017, Pages

  Bowen, James R ^a,b   Quicke, Kendra M ^a,b   Maddur, Mohan S ^a,b   O’Neal, Justin T ^a,b   McDonald, Circe E ^a,b   Fedorova, Nadia B ^c   Puri, Vinita ^c   Shabman, Reed S ^c   Pulendran, Bali ^a,b   Suthar, Mehul S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c J CRAIG VENTER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BETA INTERFERON; CD40 ANTIGEN; CD86 ANTIGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 3; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LGP2 PROTEIN; PEPTIDES AND PROTEINS; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; STAT1 PROTEIN; STAT2 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIPERIN; DDX58 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; ASSAY; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; FOCUS FORMING ASSAY; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOGENICITY; MOLECULAR GENETICS; NONHUMAN; PHYLOGENY; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ATTACHMENT; VIRUS REPLICATION; WESTERN BLOTTING; ZIKA FEVER; IMMUNE EVASION; IMMUNOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY; ZIKA VIRUS;

BLOTTING, WESTERN; DEAD BOX PROTEIN 58; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNE EVASION; INTERFERON TYPE I; POLYMERASE CHAIN REACTION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85014129552     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006164     Document Type: Article

References (80)

1. Miner JJ, Cao B, Govero J, Smith AM, Fernandez E, et al. (2016) Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise. Cell165: 1081–1091. doi: 10.1016/j.cell.2016.05.00827180225
2. Driggers RW, Ho CY, Korhonen EM, Kuivanen S, Jaaskelainen AJ, et al. (2016) Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities. N Engl J Med.
3. Mlakar J, Korva M, Tul N, Popovic M, Poljsak-Prijatelj M, et al. (2016) Zika Virus Associated with Microcephaly. N Engl J Med374: 951–958. doi: 10.1056/NEJMoa160065126862926
4. Brasil P, Pereira JP, Jr.Raja Gabaglia C, Damasceno L, Wakimoto M, et al. (2016) Zika Virus Infection in Pregnant Women in Rio de Janeiro—Preliminary Report. N Engl J Med.
5. Cugola FR, Fernandes IR, Russo FB, Freitas BC, Dias JLM, et al. (2016) The Brazilian Zika virus strain causes birth defects in experimental models. Nature.
6. Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, et al. (2014) Zika virus infection complicated by Guillain-Barre syndrome—case report, French Polynesia, December 2013. Euro surveillance: bulletin Européen sur les maladies transmissibles = European communicable disease bulletin19.
7. Sharp TM, Munoz-Jordan J, Perez-Padilla J, Bello-Pagan MI, Rivera A, et al. (2016) Zika Virus Infection Associated With Severe Thrombocytopenia. Clin Infect Dis.
8. Dick GW, Kitchen SF, Haddow AJ, (1952) Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg46: 509–520. 12995440
9. Haddow AJ, Williams MC, Woodall JP, Simpson DI, Goma LK, (1964) Twelve Isolations of Zika Virus from Aedes (Stegomyia) Africanus (Theobald) Taken in and above a Uganda Forest. Bull World Health Organ31: 57–69. 14230895
10. Lanciotti RS, Lambert AJ, Holodniy M, Saavedra S, Signor Ldel C, (2016) Phylogeny of Zika Virus in Western Hemisphere, 2015. Emerg Infect Dis22: 933–935. doi: 10.3201/eid2205.16006527088323
11. Dowd KA, DeMaso CR, Pelc RS, Speer SD, Smith AR, et al. (2016) Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. Cell Rep16: 1485–1491. doi: 10.1016/j.celrep.2016.07.04927481466
12. Petersen LR, Jamieson DJ, Powers AM, Honein MA, (2016) Zika Virus. N Engl J Med374: 1552–1563. doi: 10.1056/NEJMra160211327028561
13. Adams L, Bello-Pagan M, Lozier M, Ryff KR, Espinet C, et al. (2016) Update: Ongoing Zika Virus Transmission—Puerto Rico, November 1, 2015-July 7, 2016. MMWR Morb Mortal Wkly Rep65: 774–779. doi: 10.15585/mmwr.mm6530e127490087
14. Lozier M, Adams L, Febo MF, Torres-Aponte J, Bello-Pagan M, et al. (2016) Incidence of Zika Virus Disease by Age and Sex—Puerto Rico, November 1, 2015-October 20, 2016. MMWR Morb Mortal Wkly Rep65: 1219–1223. doi: 10.15585/mmwr.mm6544a427832051
15. Likos A, Griffin I, Bingham AM, Stanek D, Fischer M, et al. (2016) Local Mosquito-Borne Transmission of Zika Virus—Miami-Dade and Broward Counties, Florida, June-August 2016. MMWR Morb Mortal Wkly Rep65: 1032–1038. doi: 10.15585/mmwr.mm6538e127684886
16. Yockey Laura J, Varela L, Rakib T, Khoury-Hanold W, Fink Susan L, et al. (2016) Vaginal Exposure to Zika Virus during Pregnancy Leads to Fetal Brain Infection. Cell166: 1247–1256.e1244. doi: 10.1016/j.cell.2016.08.00427565347
17. Davidson A, Slavinski S, Komoto K, Rakeman J, Weiss D, (2016) Suspected Female-to-Male Sexual Transmission of Zika Virus—New York City, 2016. MMWR Morb Mortal Wkly Rep65: 716–717. doi: 10.15585/mmwr.mm6528e227442327
18. D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, et al. (2016) Evidence of Sexual Transmission of Zika Virus. N Engl J Med374: 2195–2198. doi: 10.1056/NEJMc160444927074370
19. Govero J, Esakky P, Scheaffer SM, Fernandez E, Drury A, et al. (2016) Zika virus infection damages the testes in mice. Nature.
20. Motta IJ, Spencer BR, Cordeiro da Silva SG, Arruda MB, Dobbin JA, et al. (2016) Evidence for Transmission of Zika Virus by Platelet Transfusion. N Engl J Med.
21. Schmid MA, Harris E, (2014) Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication. PLoS Pathog10: e1004541. doi: 10.1371/journal.ppat.100454125474197
22. Cerny D, Haniffa M, Shin A, Bigliardi P, Tan BK, et al. (2014) Selective susceptibility of human skin antigen presenting cells to productive dengue virus infection. PLoS Pathog10: e1004548. doi: 10.1371/journal.ppat.100454825474532
23. Pinto AK, Ramos HJ, Wu X, Aggarwal S, Shrestha B, et al. (2014) Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis. PLoS Pathog10: e1004086. doi: 10.1371/journal.ppat.100408624743949
24. Robertson SJ, Lubick KJ, Freedman BA, Carmody AB, Best SM, (2014) Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function. J Immunol192: 2744–2755. doi: 10.4049/jimmunol.130211024532583
25. Aleyas AG, Han YW, George JA, Kim B, Kim K, et al. (2010) Multifront assault on antigen presentation by Japanese encephalitis virus subverts CD8+ T cell responses. J Immunol185: 1429–1441. doi: 10.4049/jimmunol.090253620581148
26. Suthar MS, Brassil MM, Blahnik G, McMillan A, Ramos HJ, et al. (2013) A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes. PLoS Pathog9: e1003168. doi: 10.1371/journal.ppat.100316823544010
27. Loo YM, Gale M, Jr. (2011) Immune signaling by RIG-I-like receptors. Immunity34: 680–692. doi: 10.1016/j.immuni.2011.05.00321616437
28. Errett JS, Suthar MS, McMillan A, Diamond MS, Gale M, Jr. (2013) The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection. J Virol87: 11416–11425. doi: 10.1128/JVI.01488-1323966395
29. Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, et al. (2010) IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog6: e1000757. doi: 10.1371/journal.ppat.100075720140199
30. Lazear HM, Pinto AK, Vogt MR, Gale M, Jr.Diamond MS, (2011) Beta interferon controls West Nile virus infection and pathogenesis in mice. J Virol85: 7186–7194. doi: 10.1128/JVI.00396-1121543483
31. Grant A, Ponia Sanket S, Tripathi S, Balasubramaniam V, Miorin L, et al. (2016) Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. Cell Host & Microbe.
32. Faria NR, Azevedo RD, Kraemer MU, Souza R, Cunha MS, et al. (2016) Zika virus in the Americas: Early epidemiological and genetic findings. Science.
33. Welsch S, Miller S, Romero-Brey I, Merz A, Bleck CK, et al. (2009) Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe5: 365–375. doi: 10.1016/j.chom.2009.03.00719380115
34. Quicke KM, Bowen JR, Johnson EL, McDonald CE, Ma H, et al. (2016) Zika Virus Infects Human Placental Macrophages. Cell Host Microbe.
35. Nybakken GE, Oliphant T, Johnson S, Burke S, Diamond MS, et al. (2005) Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature437: 764–769. doi: 10.1038/nature0395616193056
36. Liu S, DeLalio LJ, Isakson BE, Wang TT, (2016) AXL-Mediated Productive Infection of Human Endothelial Cells by Zika Virus. Circ Res119: 1183–1189. doi: 10.1161/CIRCRESAHA.116.30986627650556
37. Haddow AD, Schuh AJ, Yasuda CY, Kasper MR, Heang V, et al. (2012) Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl Trop Dis6: e1477. doi: 10.1371/journal.pntd.000147722389730
38. Li C, Xu D, Ye Q, Hong S, Jiang Y, et al. (2016) Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice. Cell Stem Cell.
39. Dang J, Tiwari SK, Lichinchi G, Qin Y, Patil VS, et al. (2016) Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3. Cell Stem Cell.
40. Garcez PP, Loiola EC, Madeiro da Costa R, Higa LM, Trindade P, et al. (2016) Zika virus impairs growth in human neurospheres and brain organoids. Science352: 816–818. doi: 10.1126/science.aaf611627064148
41. Pulendran B, (2015) The varieties of immunological experience: of pathogens, stress, and dendritic cells. Annu Rev Immunol33: 563–606. doi: 10.1146/annurev-immunol-020711-07504925665078
42. Schoggins JW, Rice CM, (2011) Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol1: 519–525. doi: 10.1016/j.coviro.2011.10.00822328912
43. Olagnier D, Scholte FE, Chiang C, Albulescu IC, Nichols C, et al. (2014) Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. J Virol88: 4180–4194. doi: 10.1128/JVI.03114-1324478443
44. Aliota MT, Caine EA, Walker EC, Larkin KE, Camacho E, et al. (2016) Characterization of Lethal Zika Virus Infection in AG129 Mice. PLoS Negl Trop Dis10: e0004682. doi: 10.1371/journal.pntd.000468227093158
45. Rossi SL, Tesh RB, Azar SR, Muruato AE, Hanley KA, et al. (2016) Characterization of a Novel Murine Model to Study Zika Virus. Am J Trop Med Hyg.
46. Lazear HM, Govero J, Smith AM, Platt DJ, Fernandez E, et al. (2016) A Mouse Model of Zika Virus Pathogenesis. Cell Host Microbe.
47. Lazear HM, Daniels BP, Pinto AK, Huang AC, Vick SC, et al. (2015) Interferon-lambda restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med7: 284ra259.
48. Prins KC, Cardenas WB, Basler CF, (2009) Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J Virol83: 3069–3077. doi: 10.1128/JVI.01875-0819153231
49. Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M, Jr.et al. (2007) Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol81: 514–524. doi: 10.1128/JVI.01265-0617079289
50. Anglero-Rodriguez YI, Pantoja P, Sariol CA, (2014) Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IkappaB kinase epsilon interaction. Clin Vaccine Immunol21: 29–38. doi: 10.1128/CVI.00500-1324173023
51. Horner SM, Park HS, Gale M, Jr. (2012) Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix alpha0. J Virol86: 3112–3120. doi: 10.1128/JVI.06727-1122238314
52. Schulz O, Pichlmair A, Rehwinkel J, Rogers NC, Scheuner D, et al. (2010) Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe7: 354–361. doi: 10.1016/j.chom.2010.04.00720478537
53. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature472: 481–485. doi: 10.1038/nature0990721478870
54. Schnell G, Loo YM, Marcotrigiano J, Gale M, Jr. (2012) Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I. PLoS Pathog8: e1002839. doi: 10.1371/journal.ppat.100283922912574
55. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M, Jr. (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature454: 523–527. doi: 10.1038/nature0710618548002
56. Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, et al. (2006) Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol80: 9424–9434. doi: 10.1128/JVI.00768-0616973548
57. Laurent-Rolle M, Boer EF, Lubick KJ, Wolfinbarger JB, Carmody AB, et al. (2010) The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol84: 3503–3515. doi: 10.1128/JVI.01161-0920106931
58. Laurent-Rolle M, Morrison J, Rajsbaum R, Macleod JM, Pisanelli G, et al. (2014) The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. Cell Host Microbe16: 314–327. doi: 10.1016/j.chom.2014.07.01525211074
59. Best SM, Morris KL, Shannon JG, Robertson SJ, Mitzel DN, et al. (2005) Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol79: 12828–12839. doi: 10.1128/JVI.79.20.12828-12839.200516188985
60. Frumence E, Roche M, Krejbich-Trotot P, El-Kalamouni C, Nativel B, et al. (2016) The South Pacific epidemic strain of Zika virus replicates efficiently in human epithelial A549 cells leading to IFN-beta production and apoptosis induction. Virology493: 217–226. doi: 10.1016/j.virol.2016.03.00627060565
61. Suthar MS, Brassil MM, Blahnik G, Gale M, Jr. (2012) Infectious clones of novel lineage 1 and lineage 2 West Nile virus strains WNV-TX02 and WNV-Madagascar. J Virol86: 7704–7709. doi: 10.1128/JVI.00401-1222573862
62. Goulet ML, Olagnier D, Xu Z, Paz S, Belgnaoui SM, et al. (2013) Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity. PLoS Pathog9: e1003298. doi: 10.1371/journal.ppat.100329823633948
63. Chambers TJ, Halevy M, Nestorowicz A, Rice CM, Lustig S, (1998) West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. J Gen Virol79 (Pt 10): 2375–2380.
64. Klimstra WB, Ryman KD, Johnston RE, (1998) Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. Journal of virology72: 7357–7366. 9696832
65. Kaul A, Woerz I, Meuleman P, Leroux-Roels G, Bartenschlager R, (2007) Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant. J Virol81: 13168–13179. doi: 10.1128/JVI.01362-0717881454
66. Shan C, Xie X, Muruato AE, Rossi SL, Roundy CM, et al. (2016) An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors. Cell Host Microbe.
67. Hamel R, Dejarnac O, Wichit S, Ekchariyawat P, Neyret A, et al. (2015) Biology of Zika Virus Infection in Human Skin Cells. J Virol89: 8880–8896. doi: 10.1128/JVI.00354-1526085147
68. Graham JB, Thomas S, Swarts J, McMillan AA, Ferris MT, et al. (2015) Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes. MBio6: e00493–00415. doi: 10.1128/mBio.00493-1525944860
69. Bol SM, van Remmerden Y, Sietzema JG, Kootstra NA, Schuitemaker H, et al. (2009) Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages. Virology390: 205–211. doi: 10.1016/j.virol.2009.05.02719535121
70. Travanty E, Zhou B, Zhang H, Di YP, Alcorn JF, et al. (2015) Differential Susceptibilities of Human Lung Primary Cells to H1N1 Influenza Viruses. J Virol89: 11935–11944. doi: 10.1128/JVI.01792-1526378172
71. Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, et al. (2006) Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med203: 413–424. doi: 10.1084/jem.2005172016461338
72. Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA, (2001) Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol75: 3501–3508. doi: 10.1128/JVI.75.8.3501-3508.200111264339
73. Tappe D, Perez-Giron JV, Zammarchi L, Rissland J, Ferreira DF, et al. (2016) Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase. Med Microbiol Immunol205: 269–273. doi: 10.1007/s00430-015-0445-726702627
74. Hanners NW, Eitson JL, Usui N, Richardson RB, Wexler EM, et al. (2016) Western Zika Virus in Human Fetal Neural Progenitors Persists Long Term with Partial Cytopathic and Limited Immunogenic Effects. Cell reports15: 2315–2322. doi: 10.1016/j.celrep.2016.05.07527268504
75. Bayless NL, Greenberg RS, Swigut T, Wysocka J, Blish CA, (2016) Zika Virus Infection Induces Cranial Neural Crest Cells to Produce Cytokines at Levels Detrimental for Neurogenesis. Cell Host Microbe20: 423–428. doi: 10.1016/j.chom.2016.09.00627693308
76. Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, et al. (2015) Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant. J Virol89: 10612–10624. doi: 10.1128/JVI.01526-1526269188
77. Kulkarni RR, Rasheed MA, Bhaumik SK, Ranjan P, Cao W, et al. (2014) Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity. J Virol88: 13990–14001. doi: 10.1128/JVI.02273-1425253340
78. Pattabhi S, Wilkins CR, Dong R, Knoll ML, Posakony J, et al. (2015) Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway. J Virol90: 2372–2387. doi: 10.1128/JVI.02202-1526676770
79. Moser LA, Ramirez-Carvajal L, Puri V, Pauszek SJ, Matthews K, et al. (2016) A Universal Next-Generation Sequencing Protocol To Generate Noninfectious Barcoded cDNA Libraries from High-Containment RNA Viruses. mSystems1: 15.
80. Wang S, Sundaram JP, Stockwell TB, (2012) VIGOR extended to annotate genomes for additional 12 different viruses. Nucleic Acids Res40: W186–192. doi: 10.1093/nar/gks52822669909